Abstract
Purpose
Circular RNAs (circRNAs) constitute a class of regulatory RNAs that are thought to play important roles in tumor initiation and progression. Several studies have reported that circRNAs may be involved in various biological processes via networks of competing endogenous RNAs (ceRNAs). However, the regulatory roles and underlying mechanisms of circRNAs in cervical cancer (CC) still largely remain to be resolved.
Methods
CircNFATC3 (hsa_circ_0005615) expression was assessed in CC cell lines (SiHa, H8) using circRNA microarray analysis, whereas qRT-PCR was used to detect circNFATC3 and miR-9-5p expression in primary human CC tissues and cell lines. The tumor promoting role of circNFATC3 was verified in CC cells using a series of functional assays, and interactions between circNFATC3, miR-9-5p and syndecan-2 (SDC2) were investigated using dual-luciferase reporter assays. SDC2 protein expression was detected using Western blotting and immunohistochemistry. The tumor promoting role of circNFATC3 was confirmed in vivo using a CC xenograft model.
Results
We found that circNFATC3 expression was upregulated in primary CC tissues and positively correlated with CC tumor size and stromal invasion. In addition, we found that exogenous circNFATC3 overexpression enhanced the proliferation, migration and invasion of HeLa cells, while its knockdown reduced the malignancy of SiHa cells. We also found that circNFATC3 may act directly as a miR-9-5p sponge to regulate SDC2 expression and its downstream signaling pathways, thereby enhancing CC development.
Conclusion
Our data indicate that circNFATC3 sponges miR-9-5p to regulate SDC2 expression and, thereby, to promote CC tumor development.
Similar content being viewed by others
Abbreviations
- CC:
-
cervical cancer
- ceRNA:
-
competing endogenous RNA
- LACC:
-
locally advanced cervical cancer
- FIGO:
-
International Federation of Gynecology and Obstetrics
- MEM:
-
minimum Eagle’s medium.
- DMEM:
-
Dulbecco’s modified Eagle’s medium.
- qRT-PCR:
-
quantitative reverse transcription-polymerase chain reaction.
- OE:
-
overexpression.
- SDC2:
-
syndecan-2.
- siRNA:
-
short interfering RNA.
- miRNA:
-
microRNA.
References
P.A. Cohen, A. Jhingran, A. Oaknin, L. Denny, Cervical cancer. Lancet 393, 169–182 (2019)
E.J. Crosbie, M.H. Einstein, S. Franceschi, H.C. Kitchener, Human papillomavirus and cervical cancer. Lancet 382, 889–899 (2013)
L. Chen, K. Liao, C. Chen, P. Li, W. Wang, A. Lu, Q. Zhu, E. Dai, D. Li, B. Ling, P. Liu, J. Lang, Investigation and analysis of the treatment status of locally advanced cervical cancer in some parts of mainland China. Chinese Journal of Practical Gynecology and Obstetrics 34, 1247–1252 (2018)
S. Memczak, M. Jens, A. Elefsinioti, F. Torti, J. Krueger, A. Rybak, L. Maier, S.D. Mackowiak, L.H. Gregersen, M. Munschauer, A. Loewer, U. Ziebold, M. Landthaler, C. Kocks, F. le Noble, N. Rajewsky, Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333–338 (2013)
Y. Zhong, Y. Du, X. Yang, Y. Mo, C. Fan, F. Xiong, D. Ren, X. Ye, C. Li, Y. Wang, F. Wei, C. Guo, X. Wu, X. Li, Y. Li, G. Li, Z. Zeng, W. Xiong, Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer 17, 79 (2018)
F. Zheng, M. Wang, Y. Li, C. Huang, D. Tao, F. Xie, H. Zhang, J. Sun, C. Zhang, C. Gu, Z. Wang, G. Jiang, CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression. Cancer Lett 460, 139–151 (2019)
J. Lu, Y.H. Wang, C. Yoon, X.Y. Huang, Y. Xu, J.W. Xie, J.B. Wang, J.X. Lin, Q.Y. Chen, L.L. Cao, C.H. Zheng, P. Li, C.M. Huang, Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis. Cancer Lett 471, 38–48 (2019)
S. Meng, H. Zhou, Z. Feng, Z. Xu, Y. Tang, P. Li, M. Wu, CircRNA: Functions and properties of a novel potential biomarker for cancer. Mol Cancer 16, 94 (2017)
Q. Zheng, C. Bao, W. Guo, S. Li, J. Chen, B. Chen, Y. Luo, D. Lyu, Y. Li, G. Shi, L. Liang, J. Gu, X. He, S. Huang, Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun 7, 11215 (2016)
L.S. Kristensen, T.B. Hansen, M.T. Venø, J. Kjems, Circular RNAs in cancer: Opportunities and challenges in the field. Oncogene 37, 555–565 (2018)
P. Glažar, P. Papavasileiou, N. Rajewsky, circBase: a database for circular RNAs. RNA 20, 1666–1670 (2014)
S. Chaichian, R. Shafabakhsh, S.M. Mirhashemi, B. Moazzami, Z. Asemi, Circular RNAs: A novel biomarker for cervical cancer. J Cell Physiol 235, 718–724 (2020)
Q. Tang, Z. Chen, L. Zhao, H. Xu, Circular RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical cancer progression through up-regulation of ELK1. Aging 11, 9982–9999 (2019)
D.P. Bartel, MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004)
R. Garzon, G. Marcucci, C.M. Croce, Targeting microRNAs in cancer: Rationale, strategies and challenges. Nat Rev Drug Discov 9, 775–789 (2010)
M. Coolen, S. Katz, L. Bally-Cuif, miR-9: a versatile regulator of neurogenesis. Front Cell Neurosci 7, 220 (2013)
M. Wang, Q. Gao, Y. Chen, Z. Li, L. Yue, Y. Cao, PAK4, a target of miR-9-5p, promotes cell proliferation and inhibits apoptosis in colorectal cancer. Cell Mol Biol Lett 24, 58 (2019)
Y. Fan, Y. Shi, Z. Lin, X. Huang, J. Li, W. Huang, D. Shen, G. Zhuang, W. Liu, miR-9-5p suppresses malignant biological behaviors of human gastric cancer cells by negative regulation of TNFAIP8L3. Dig Dis Sci 64, 2823–2829 (2019)
J. Wang, B. Wang, H. Ren, W. Chen, miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1. Biochem Biophys Res Commun 509, 241–248 (2019)
G. Li, F. Wu, H. Yang, X. Deng, Y. Yuan, MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2. Biomed Pharmacother 96, 1170–1178 (2017)
H. Lee, Y. Kim, Y. Choi, S. Choi, E. Hong, E.S. Oh, Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1. Biochem Biophys Res Commun 409, 148–153 (2011)
K. Tsoyi, J.C. Osorio, S.G. Chu, I.E. Fernandez, S.P. De Frias, L. Sholl, Y. Cui, C.S. Tellez, J.M. Siegfried, S.A. Belinsky, M.A. Perrella, S. El-Chemaly, I.O. Rosas, Lung adenocarcinoma syndecan-2 potentiates cell invasiveness. Am J Respir Cell Mol Biol 60, 659–666 (2019)
T. De Oliveira, I. Abiatari, S. Raulefs, D. Sauliunaite, M. Erkan, B. Kong, H. Friess, C.W. Michalski, J. Kleeff, Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype. Mol Cancer 11, 19 (2012)
A. Jacob, R. Prekeris, The regulation of MMP targeting to invadopodia during cancer metastasis. Front Cell Dev Biol 3, 4 (2015)
D.J. Carey, Syndecans: multifunctional cell-surface co-receptors. Biochem J. 327 ( Pt 1), (1997)
J.J. Grootjans, P. Zimmermann, G. Reekmans, A. Smets, G. Degeest, J. Dürr, G. David, Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci U S A 94, 13683–13688 (1997)
Y. Choi, H. Kim, H. Chung, J.S. Hwang, J.A. Shin, I.O. Han, E.S. Oh, Syndecan-2 regulates cell migration in colon cancer cells through Tiam1-mediated Rac activation. Biochem Biophys Res Commun 391, 921–925 (2010)
Y. Xia, S. Shen, I.M. Verma, NF-κB, an active player in human cancers. Cancer Immunol Res 2, 823–830 (2014)
S. Tilborghs, J. Corthouts, Y. Verhoeven, D. Arias, C. Rolfo, X.B. Trinh, P.A. van Dam, The role of nuclear factor-kappa B signaling in human cervical cancer. Crit Rev Oncol Hematol 120, 141–150 (2017)
D. Hanahan, R.A. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646–674 (2011)
M. Qiu, W. Xia, R. Chen, S. Wang, Y. Xu, Z. Ma, W. Xu, E. Zhang, J. Wang, T. Fang, J. Hu, G. Dong, R. Yin, J. Wang, L. Xu, The circular RNA circPRKCI promotes tumor growth in lung adenocarcinoma. Cancer Res 78, 2839–2851 (2018)
J. Zhang, H. Liu, L. Hou, G. Wang, R. Zhang, Y. Huang, X. Chen, J. Zhu, Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression. Mol Cancer 16, 151 (2017)
Z.H. Zong, Y.P. Du, X. Guan, S. Chen, Y. Zhao, CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182. J Exp Clin Cancer Res 38, 437 (2019)
H.B. Ma, Y.N. Yao, J.J. Yu, X.X. Chen, H.F. Li, Extensive profiling of circular RNAs and the potential regulatory role of circRNA-000284 in cell proliferation and invasion of cervical cancer via sponging miR-506. Am J Transl Res 10, 592–604 (2018)
L.T. Maria, F. Raffaella, B. Luigi, A. Clorinda, S. Noemy, C. Andrea, P. Francesca, L.T. Anna, M.B. Franco, The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical Cance. Front Oncol 10, 150 (2020)
L.S. Kristensen, M.S. Andersen, L.V.W. Stagsted, K.K. Ebbesen, T.B. Hansen, J. Kjems, The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 20, 675–691 (2019)
S.M. Wilting, P.J.F. Snijders, W. Verlaat, A. Jaspers, M.A. van de Wiel, W.N. van Wieringen, G.A. Meijer, G.G. Kenter, Y. Yi, C. le Sage, R. Agami, C.J.L.M. Meijer, R.D.M. Steenbergen, Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 32, 106–116 (2013)
Z.-M. Zheng, X. Wang, Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta 1809, 668–677 (2011)
Q. Xie, S. Lin, M. Zheng, Q. Cai, Y. Tu, Long noncoding RNA NEAT1 promotes the growth of cervical cancer cells via sponging miR-9-5p. Biochem Cell Biol 97, 100–108 (2019)
A. Aishanjiang, N. Rouzi, Z. Jiao, L. Wang, K. Wusainahong, N. Wumanjiang, M. Musha, M. Niyazi, MicroRNA-9 enhances invasion and migration of cervical carcinomas by directly targeting FOXO1. Eur Rev Med Pharmacol Sci 22, 2253–2260 (2018)
I. Babion, A. Jaspers, A.P. van Splunter, I.A.E. van der Hoorn, S.M. Wilting, R.D.M. Steenbergen, miR-9-5p exerts a dual role in cervical cancer and targets transcription factor TWIST1. Cells 9, 65 (2019)
W. Liu, G. Gao, X. Hu, Y. Wang, J.K. Schwarz, J.J. Chen, P.W. Grigsby, X. Wang, Activation of miR-9 by human papillomavirus in cervical cancer. Oncotarget 5, 11620–11630 (2014)
Availability of data and materials
The datasets used and/or analyzed during this study are available from the corresponding author upon reasonable request.
Funding
This work was supported by the Free Researcher Project of Shengjing Hospital (grant no. 201302).
Author information
Authors and Affiliations
Contributions
SLZ designed the study; NYM conducted the experiments and wrote the paper; HW, XHL and WH performed part of the experiments and analyzed the data. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors have declared that no competing interests exist
Ethical approval and consent to participate
This study (including animal studies) was approved by the Ethics Committee of Shengjing Hospital of China Medical University and was conducted in accordance with the Declaration of Helsinki.
Consent for publication
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ma, N., Li, X., Wei, H. et al. Circular RNA circNFATC3 acts as a miR-9-5p sponge to promote cervical cancer development by upregulating SDC2. Cell Oncol. 44, 93–107 (2021). https://doi.org/10.1007/s13402-020-00555-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-020-00555-z